Signage at a Novavax facility in Gaithersburg, Maryland, US, on Aug. 26, 2024. Novavax shares earlier this month dropped 14% in premarket trading after the vaccine-maker reported revenue for the second quarter that missed the average analyst estimate and updated its guidance for the year.
Mandatory Credit:	Graeme Sloan/Bloomberg/Getty Images via CNN Newsource

Signage at a Novavax facility in Gaithersburg, Maryland, US, on Aug. 26, 2024. Novavax shares earlier this month dropped 14% in premarket trading after the vaccine-maker reported revenue for the second quarter that missed the average analyst estimate and updated its guidance for the year.
Mandatory Credit: Graeme Sloan/Bloomberg/Getty Images via CNN Newsource

Stories this photo appears in:

Tease photo

Updated Novavax Covid-19 vaccines could be available as early as next week

The US Food and Drug Administration on Friday authorized an updated version of the protein-based Novavax Covid-19 vaccine for use in people 12 and up. Doses could be available by the end of next week.